178 filings
8-K
IRON
Disc Medicine Inc
2 Apr 24
Regulation FD Disclosure
5:25pm
S-8
IRON
Disc Medicine Inc
21 Mar 24
Registration of securities for employees
8:54am
10-K
2023 FY
IRON
Disc Medicine Inc
Annual report
21 Mar 24
8:15am
8-K
IRON
Disc Medicine Inc
21 Mar 24
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
8:00am
8-K
IRON
Disc Medicine Inc
26 Feb 24
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
8:43am
8-K
wbazvzu41nq
7 Feb 24
Departure of Directors or Certain Officers
8:10am
8-K
qr8zlxub 1euw
11 Dec 23
Regulation FD Disclosure
8:35pm
8-K
cck57qwu
11 Dec 23
Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of
12:11pm
EFFECT
jvgbgwqz079vo6wiww
7 Dec 23
Notice of effectiveness
12:15am
8-K
cl5 ql8ug3afbkf
5 Dec 23
Entry into a Material Definitive Agreement
4:56pm
POS AM
pcaqni5v
5 Dec 23
Prospectus update (post-effective amendment)
4:53pm
424B5
tkm zilut37g
5 Dec 23
Prospectus supplement for primary offering
4:51pm
EFFECT
9vmxyy
30 Nov 23
Notice of effectiveness
12:15am
CORRESP
k1b3j 3ynmw1
27 Nov 23
Correspondence with SEC
12:00am
UPLOAD
9pq1ag
27 Nov 23
Letter from SEC
12:00am
8-K
5t1 1xlqxg
9 Nov 23
Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update
8:35am
8-K
8pcasih k9
2 Nov 23
Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of
9:05am
8-K
wfhyclov
23 Oct 23
Disc Medicine Announces Planned Departure of Chief Financial Officer Joanne Bryce
9:15am